Esoprol 40 mg/vial (IV Injection)
40 mg vial: ৳ 100.00
Medicine Details
Category | Details |
---|---|
Generic | Esomeprazole |
Company | Ziska pharmaceuticals ltd |
Also available as |
Indications
- Relief from chronic heartburn symptoms
- Healing of erosive esophagitis
- Maintenance of healing of erosive esophagitis
- Eradication of Helicobacter pylori infection in patients with duodenal ulcer disease
- Treatment of Zollinger-Ellison Syndrome
- Management of Acid-related Dyspepsia
- Treatment of Duodenal & Gastric ulcer
Pharmacology
- Proton pump inhibitor
- Suppression of gastric acid secretion
- Inhibition of the H+/K+-ATPase in the gastric parietal cell
- Enteric-coated pellet formulation of esomeprazole magnesium
- Absorption peak plasma levels occur at approximately 1.5 hours
- Systemic bioavailability is approximately 90%
- Plasma protein binding is constant over the concentration range
- Metabolized in the liver by the cytochrome P450 (CYP) enzyme system
- Plasma elimination half-life is approximately 1–1.5 hours
Dosage
- Oral dosage form for healing of erosive esophagitis, symptomatic GERD, Helicobacter Pylori eradication, Zollinger-Ellison Syndrome, Acid-related Dyspepsia, Duodenal & Gastric ulcer
- IV Injection or IV infusion for GERD with Erosive Esophagitis, Risk reduction of rebleeding of Gastric or Duodenal Ulcers in adults
- Dosage adjustment for pediatric patients
Administration
- Tablet or capsule should be swallowed whole and taken one hour before a meal
- Oral Suspension should be taken with water and stirred well
- IV Injection solution for injection is prepared by adding 0.9% Sodium Chloride
- IV injection must be administered intravenously over a period of at least 3 minutes
Interaction
- Metabolized in the liver by CYP2C19 and CYP3A4
- Not likely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1 and 3A4
- Potential interference with the absorption of drugs where gastric pH is important
- Increased plasma levels observed with diazepam
Contraindications
- Known hypersensitivity to any of the formulation
Side Effects
- Headache
- Diarrhea
- Nausea
- Flatulence
- Abdominal pain
- Constipation
- Dry mouth
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- Animal studies have revealed no teratogenic effects
- Excretion in milk not studied
- Breast-feeding should be discontinued if essential
Precautions & Warnings
- Symptomatic response does not preclude the presence of gastric malignancy
- Tablet/capsule can be mixed with applesauce for swallowing
- Antacids may be used while taking
Use in Special Populations
- Safety and effectiveness in pediatric patients not established
- No overall differences in safety and efficacy observed in geriatric use
- No dosage adjustment recommended for patients with mild to moderate hepatic insufficiency
- Pharmacokinetics not expected to be altered in patients with renal impairment
Overdose Effects
- Major signs of acute toxicity include reduced motor activity, changes in respiratory frequency, tremors, and clonic convulsions
- No specific antidote known
Storage Conditions
- Store at a temperature not exceeding 30°C in a dry place
- Protect from light and moisture
- Keep out of reach of children
Chemical Structure
- Molecular Formula: C17H19N3O3S
Common Questions about Esoprol 40 mg/vial Injection
- Mechanism of action as a proton pump inhibitor
- Multiple uses including treatment of heartburn, ulcers, and conditions involving excessive stomach acid
- Common side effects such as headaches, diarrhea, and nausea
- Considerations for pregnant or breastfeeding individuals
- Quick tips for medication usage and potential side effects
Related Brands
- Espazole 20 mg (Capsule (Enteric Coated)) - arges-life-science-limited
- Esogel 40 mg/vial (IV Injection) - novatek-pharmaceuticals-ltd
- Esmosec 40 mg/vial (IV Injection) - techno-drugs-ltd
- Esmosec 40 mg (Tablet (Enteric Coated)) - techno-drugs-ltd
- Esompus 20 mg (Tablet (Enteric Coated)) - radius-pharmaceuticals-ltd